SELLAS Life Sciences Group, Inc. (SLS) Misses Q1 EPS by 18c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q1 EPS of ($0.47), $0.18 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
• Bending Spoons closes IPO, raises ~$954M on Nasdaq